









Markets
/
Stocks
/
nasdaq-rvty
/

Revvity Inc

RVTY

93.590USD

+2.570+2.82%

Close 10/31, 16:00（ET）Quotes delayed by 15 min

10.86BMarket Cap

45.74P/E TTM



Revvity Inc

93.590

+2.570+2.82%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Revvity Inc

Currency: USD Updated: 2025-10-31

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Revvity Inc's Score

Industry at a Glance

Industry Ranking

41 / 210

Overall Ranking

128 / 4618

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 20 analysts

Buy

Current Rating

119.763

Target Price

+31.58%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Revvity Inc Highlights

StrengthsRisks

Revvity, Inc. is a provider of health science solutions, technologies, and services, which delivers workflows from discovery to development, and diagnosis to cure. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The Life Sciences Segment applications include MicroBeta, The MuviCyte live-cell imaging system, The Signals Image Artist, The VICTOR Nivo multimode plate reader benchtop system, The EnSight multimode plate reader benchtop system, BioLegend LEGENDplex bead-based reagents, and The Quantum GX2 system. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. It offers instruments, reagents, assay platforms and software to hospitals, and medical labs. It is focused on reproductive health, immunodiagnostics, and emerging market diagnostics.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 12.14%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 12.14%.

Fairly Valued

The company’s latest PE is 47.05, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 117.08M shares, decreasing 6.70% quarter-over-quarter.

Held by EDGEPOINT CANADIAN PORTFOLIO

Star Investor EDGEPOINT CANADIAN PORTFOLIO holds 6.79M shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-31

The company's current financial score is 7.65, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 698.95M, representing a year-over-year increase of 2.18%, while its net profit experienced a year-over-year increase of 50.56%.

Score

Industry at a Glance

Previous score

7.65

Change



Financials

6.63

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.38

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.19

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.60

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

8.46

Key Metrics

Free cash flow

No Data

Revvity Inc's Company Valuation

Currency: USD Updated: 2025-10-31

The company’s current valuation score is 6.96, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 47.05, which is 92.27% below the recent high of 90.45 and 70.54% above the recent low of 13.86.

Score

Industry at a Glance

Previous score

6.96

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 41/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-31

The company’s current earnings forecast score is 7.60, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Revvity Inc is 115.00, with a high of 185.00 and a low of 85.00.

Score

Industry at a Glance

Previous score

7.60

Change

Support & Resistance

No Data

Analyst Rating

Based on 20 analysts

Buy

Current Rating

119.763

Target Price

+31.58%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Revvity Inc

RVTY

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-31

The company’s current price momentum score is 6.99, which is higher than the Healthcare Equipment & Supplies industry's average of 6.65. Sideways: Currently, the stock price is trading between the resistance level at 99.98 and the support level at 87.63, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.64

Change

0.35

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.742

Neutral

RSI(14)

51.673

Neutral

STOCH(KDJ)(9,3,3)

27.927

Sell

ATR(14)

3.206

Low Volatility

CCI(14)

-75.288

Neutral

Williams %R

58.491

Sell

TRIX(12,20)

0.365

Sell

StochRSI(14)

36.306

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

94.704

Sell

MA10

95.786

Sell

MA20

93.791

Sell

MA50

89.781

Buy

MA100

92.114

Buy

MA200

98.383

Sell

Institutional Confidence

Currency: USD Updated: 2025-10-31

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 100.87%, representing a quarter-over-quarter increase of 2.90%. The largest institutional shareholder is The Vanguard, holding a total of 14.03M shares, representing 12.09% of shares outstanding, with 3.34% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

T. Rowe Price Investment Management, Inc.

22.64M

+0.56%

The Vanguard Group, Inc.

Star Investors

14.03M

-2.08%

T. Rowe Price Associates, Inc.

Star Investors

7.80M

-16.90%

Janus Henderson Investors

7.22M

+20.47%

EdgePoint Investment Group Inc.

Star Investors

6.79M

+26.65%

BlackRock Institutional Trust Company, N.A.

5.81M

-4.28%

State Street Investment Management (US)

5.02M

-2.91%

Geode Capital Management, L.L.C.

2.98M

-0.62%

Capital Research Global Investors

2.66M

-6.44%

Invesco Capital Management LLC

Star Investors

1.94M

+27.88%

Risk Assessment

Currency: USD Updated: 2025-10-31

The company’s current risk assessment score is 6.54, which is higher than the Healthcare Equipment & Supplies industry's average of 4.56. The company's beta value is 1.01. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.